HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML)
- 28 April 2000
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 14 (5) , 859-862
- https://doi.org/10.1038/sj.leu.2401774
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 21 references indexed in Scilit:
- Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia.Journal of Clinical Investigation, 1998
- HLA gene and haplotype frequencies in bone marrow donors worldwide registriesHuman Immunology, 1997
- HLA gene and haplotype frequencies in Dutch blood donorsTissue Antigens, 1996
- A molecular model of MHC class-I-restricted antigen processingImmunology Today, 1992
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1Epidemiologic Reviews, 1987
- Fused transcript of abl and bcr genes in chronic myelogenous leukaemiaNature, 1985
- A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa StainingNature, 1973
- THE ESTIMATION AND SIGNIFICANCE OF THE LOGARITHM OF A RATIO OF FREQUENCIESAnnals of Human Genetics, 1956
- ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASEAnnals of Human Genetics, 1955